IM Cannabis Statistics
Total Valuation
IM Cannabis has a market cap or net worth of $11.49 million. The enterprise value is $20.42 million.
Important Dates
The last earnings date was Thursday, May 15, 2025, before market open.
| Earnings Date | May 15, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
IM Cannabis has 3.09 million shares outstanding. The number of shares has increased by 15.25% in one year.
| Current Share Class | 3.09M |
| Shares Outstanding | 3.09M |
| Shares Change (YoY) | +15.25% |
| Shares Change (QoQ) | +14.22% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 1.45M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.30 |
| Forward PS | 0.18 |
| PB Ratio | 5.20 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 4.07 |
| P/OCF Ratio | 4.11 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.54 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 7.24 |
Financial Position
The company has a current ratio of 0.72, with a Debt / Equity ratio of 4.97.
| Current Ratio | 0.72 |
| Quick Ratio | 0.44 |
| Debt / Equity | 4.97 |
| Debt / EBITDA | n/a |
| Debt / FCF | 3.89 |
| Interest Coverage | -1.81 |
Financial Efficiency
Return on equity (ROE) is -96.83% and return on invested capital (ROIC) is -22.03%.
| Return on Equity (ROE) | -96.83% |
| Return on Assets (ROA) | -10.46% |
| Return on Invested Capital (ROIC) | -22.03% |
| Return on Capital Employed (ROCE) | -173.89% |
| Revenue Per Employee | $398,892 |
| Profits Per Employee | -$34,325 |
| Employee Count | 95 |
| Asset Turnover | 1.27 |
| Inventory Turnover | 6.65 |
Taxes
| Income Tax | -654,677 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -4.98% in the last 52 weeks. The beta is 3.17, so IM Cannabis's price volatility has been higher than the market average.
| Beta (5Y) | 3.17 |
| 52-Week Price Change | -4.98% |
| 50-Day Moving Average | 1.90 |
| 200-Day Moving Average | 2.20 |
| Relative Strength Index (RSI) | 53.24 |
| Average Volume (20 Days) | 631,451 |
Short Selling Information
The latest short interest is 16,126, so 0.52% of the outstanding shares have been sold short.
| Short Interest | 16,126 |
| Short Previous Month | 20,732 |
| Short % of Shares Out | 0.52% |
| Short % of Float | 1.11% |
| Short Ratio (days to cover) | 1.43 |
Income Statement
In the last 12 months, IM Cannabis had revenue of $37.89 million and -$3.26 million in losses. Loss per share was -$1.27.
| Revenue | 37.89M |
| Gross Profit | 7.04M |
| Operating Income | -5.01M |
| Pretax Income | -10.42M |
| Net Income | -3.26M |
| EBITDA | -3.88M |
| EBIT | -5.01M |
| Loss Per Share | -$1.27 |
Full Income StatementBalance Sheet
The company has $966,362 in cash and $10.98 million in debt, giving a net cash position of -$10.01 million or -$3.24 per share.
| Cash & Cash Equivalents | 966,362 |
| Total Debt | 10.98M |
| Net Cash | -10.01M |
| Net Cash Per Share | -$3.24 |
| Equity (Book Value) | 2.21M |
| Book Value Per Share | 1.20 |
| Working Capital | -7.84M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $2.79 million and capital expenditures -$107,142, giving a free cash flow of $2.82 million.
| Operating Cash Flow | 2.79M |
| Capital Expenditures | -107,142 |
| Free Cash Flow | 2.82M |
| FCF Per Share | $0.91 |
Full Cash Flow StatementMargins
Gross margin is 18.58%, with operating and profit margins of -13.22% and -8.61%.
| Gross Margin | 18.58% |
| Operating Margin | -13.22% |
| Pretax Margin | -11.96% |
| Profit Margin | -8.61% |
| EBITDA Margin | -10.25% |
| EBIT Margin | -13.22% |
| FCF Margin | 7.45% |
Dividends & Yields
IM Cannabis does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.25% |
| Shareholder Yield | -15.25% |
| Earnings Yield | -28.38% |
| FCF Yield | 24.56% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 12, 2024. It was a reverse split with a ratio of 0.1666667:1.
| Last Split Date | Jul 12, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.1666667:1 |
Scores
IM Cannabis has an Altman Z-Score of -7.53 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -7.53 |
| Piotroski F-Score | 6 |